103 related articles for article (PubMed ID: 1382143)
1. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes.
Sellon DC; Perry ST; Coggins L; Fuller FJ
J Virol; 1992 Oct; 66(10):5906-13. PubMed ID: 1382143
[TBL] [Abstract][Full Text] [Related]
2. Host cell restriction factors of equine infectious anemia virus.
Wang XF; Zhang X; Ma W; Li J; Wang X
Virol Sin; 2023 Aug; 38(4):485-496. PubMed ID: 37419416
[TBL] [Abstract][Full Text] [Related]
3. Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities.
Lohia A; Sahel DK; Salman M; Singh V; Mariappan I; Mittal A; Chitkara D
Asian J Pharm Sci; 2022 Mar; 17(2):153-176. PubMed ID: 36320315
[TBL] [Abstract][Full Text] [Related]
4. Equine lentivirus counteracts SAMHD1 restriction by Rev-mediated degradation of SAMHD1 via the BECN1-dependent lysosomal pathway.
Ren H; Yin X; Su C; Guo M; Wang XF; Na L; Lin Y; Wang X
Autophagy; 2021 Oct; 17(10):2800-2817. PubMed ID: 33172327
[TBL] [Abstract][Full Text] [Related]
5. Interplay of ancestral non-primate lentiviruses with the virus-restricting SAMHD1 proteins of their hosts.
Mereby SA; Maehigashi T; Holler JM; Kim DH; Schinazi RF; Kim B
J Biol Chem; 2018 Oct; 293(42):16402-16412. PubMed ID: 30181218
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy and genome surgery in the retina.
DiCarlo JE; Mahajan VB; Tsang SH
J Clin Invest; 2018 Jun; 128(6):2177-2188. PubMed ID: 29856367
[TBL] [Abstract][Full Text] [Related]
7. Infection with equine infectious anemia virus vaccine strain EIAVDLV121 causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response.
Liu Q; Ma J; Wang XF; Xiao F; Li LJ; Zhang JE; Lin YZ; Du C; He XJ; Wang X; Zhou JH
Vet Immunol Immunopathol; 2016 Feb; 170():30-40. PubMed ID: 26832985
[TBL] [Abstract][Full Text] [Related]
8. Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection.
Du C; Ma J; Liu Q; Li YF; He XJ; Lin YZ; Wang XF; Meng QW; Wang X; Zhou JH
Retrovirology; 2015 Apr; 12():36. PubMed ID: 25928027
[TBL] [Abstract][Full Text] [Related]
9. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.
Tang YD; Na L; Zhu CH; Shen N; Yang F; Fu XQ; Wang YH; Fu LH; Wang JY; Lin YZ; Wang XF; Wang X; Zhou JH; Li CY
J Virol; 2014 Nov; 88(21):12296-310. PubMed ID: 25122784
[TBL] [Abstract][Full Text] [Related]
10. Interstitial lung disease associated with Equine Infectious Anemia Virus infection in horses.
Bolfa P; Nolf M; Cadoré JL; Catoi C; Archer F; Dolmazon C; Mornex JF; Leroux C
Vet Res; 2013 Dec; 44(1):113. PubMed ID: 24289102
[TBL] [Abstract][Full Text] [Related]
11. Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt disease.
Binley K; Widdowson P; Loader J; Kelleher M; Iqball S; Ferrige G; de Belin J; Carlucci M; Angell-Manning D; Hurst F; Ellis S; Miskin J; Fernandes A; Wong P; Allikmets R; Bergstrom C; Aaberg T; Yan J; Kong J; Gouras P; Prefontaine A; Vezina M; Bussieres M; Naylor S; Mitrophanous KA
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4061-71. PubMed ID: 23620430
[TBL] [Abstract][Full Text] [Related]
12. The inside out of lentiviral vectors.
Durand S; Cimarelli A
Viruses; 2011 Feb; 3(2):132-159. PubMed ID: 22049307
[TBL] [Abstract][Full Text] [Related]
13. Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.
Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Zhou J
Virus Genes; 2011 Apr; 42(2):220-8. PubMed ID: 21369830
[TBL] [Abstract][Full Text] [Related]
14. Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.
Zielonka J; Bravo IG; Marino D; Conrad E; Perković M; Battenberg M; Cichutek K; Münk C
J Virol; 2009 Aug; 83(15):7547-59. PubMed ID: 19458006
[TBL] [Abstract][Full Text] [Related]
15. Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.
Bogerd HP; Tallmadge RL; Oaks JL; Carpenter S; Cullen BR
J Virol; 2008 Dec; 82(23):11889-901. PubMed ID: 18818324
[TBL] [Abstract][Full Text] [Related]
16. An equine infectious anemia virus variant superinfects cells through novel receptor interactions.
Brindley MA; Zhang B; Montelaro RC; Maury W
J Virol; 2008 Oct; 82(19):9425-32. PubMed ID: 18667522
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
[TBL] [Abstract][Full Text] [Related]
18. Equine infectious anemia virus entry occurs through clathrin-mediated endocytosis.
Brindley MA; Maury W
J Virol; 2008 Feb; 82(4):1628-37. PubMed ID: 18057237
[TBL] [Abstract][Full Text] [Related]
19. Although macrophage-tropic simian/human immunodeficiency viruses can exhibit a range of pathogenic phenotypes, a majority of isolates induce no clinical disease in immunocompetent macaques.
Igarashi T; Donau OK; Imamichi H; Nishimura Y; Theodore TS; Iyengar R; Erb C; Buckler-White A; Buckler CE; Martin MA
J Virol; 2007 Oct; 81(19):10669-79. PubMed ID: 17626082
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo.
Marsden MD; Zack JA
J Virol; 2007 Jun; 81(11):6146-50. PubMed ID: 17392373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
